Literature DB >> 25946144

Diabetic foot complications and their risk factors from a large retrospective cohort study.

Khalid Al-Rubeaan1, Mohammad Al Derwish2, Samir Ouizi2, Amira M Youssef3, Shazia N Subhani4, Heba M Ibrahim3, Bader N Alamri5.   

Abstract

BACKGROUND: Foot complications are considered to be a serious consequence of diabetes mellitus, posing a major medical and economical threat. Identifying the extent of this problem and its risk factors will enable health providers to set up better prevention programs. Saudi National Diabetes Registry (SNDR), being a large database source, would be the best tool to evaluate this problem.
METHODS: This is a cross-sectional study of a cohort of 62,681 patients aged ≥ 25 years from SNDR database, selected for studying foot complications associated with diabetes and related risk factors.
RESULTS: The overall prevalence of diabetic foot complications was 3.3% with 95% confidence interval (95% CI) of (3.16%-3.44%), whilst the prevalences of foot ulcer, gangrene, and amputations were 2.05% (1.94%-2.16%), 0.19% (0.16%-0.22%), and 1.06% (0.98%-1.14%), respectively. The prevalence of foot complications increased with age and diabetes duration predominantly amongst the male patients. Diabetic foot is more commonly seen among type 2 patients, although it is more prevalent among type 1 diabetic patients. The Univariate analysis showed Charcot joints, peripheral vascular disease (PVD), neuropathy, diabetes duration ≥ 10 years, insulin use, retinopathy, nephropathy, age ≥ 45 years, cerebral vascular disease (CVD), poor glycemic control, coronary artery disease (CAD), male gender, smoking, and hypertension to be significant risk factors with odds ratio and 95% CI at 42.53 (18.16-99.62), 14.47 (8.99-23.31), 12.06 (10.54-13.80), 7.22 (6.10-8.55), 4.69 (4.28-5.14), 4.45 (4.05-4.89), 2.88 (2.43-3.40), 2.81 (2.31-3.43), 2.24 (1.98-2.45), 2.02 (1.84-2.22), 1.54 (1.29-1.83), and 1.51 (1.38-1.65), respectively.
CONCLUSIONS: Risk factors for diabetic foot complications are highly prevalent; they have put these complications at a higher rate and warrant primary and secondary prevention programs to minimize morbidity and mortality in addition to economic impact of the complications. Other measurements, such as decompression of lower extremity nerves, should be considered among diabetic patients.

Entities:  

Mesh:

Year:  2015        PMID: 25946144      PMCID: PMC4422657          DOI: 10.1371/journal.pone.0124446

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  54 in total

Review 1.  The Charcot foot in diabetes.

Authors:  Lee C Rogers; Robert G Frykberg; David G Armstrong; Andrew J M Boulton; Michael Edmonds; Georges Ha Van; Agnes Hartemann; Frances Game; William Jeffcoate; Alexandra Jirkovska; Edward Jude; Stephan Morbach; William B Morrison; Michael Pinzur; Dario Pitocco; Lee Sanders; Dane K Wukich; Luigi Uccioli
Journal:  J Am Podiatr Med Assoc       Date:  2011 Sep-Oct

2.  Evaluation of peripheral microcirculation improvement of foot after tarsal tunnel release in diabetic patients by transcutaneous oximetry.

Authors:  Emilio Trignano; Nefer Fallico; Hung-Chi Chen; Mario Faenza; Alfonso Bolognini; Andrea Armenti; Fabio Santanelli Di Pompeo; Corrado Rubino; Gian Vittorio Campus
Journal:  Microsurgery       Date:  2015-01-13       Impact factor: 2.425

3.  The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting.

Authors:  J J de Sonnaville; L P Colly; D Wijkel; R J Heine
Journal:  Diabetes Res Clin Pract       Date:  1997-03       Impact factor: 5.602

4.  Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study.

Authors:  Caroline A Abbott; Adam P Garrow; Anne L Carrington; Julie Morris; Ernest R Van Ross; Andrew J Boulton
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

5.  Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot.

Authors:  William R Ledoux; Jane B Shofer; Douglas G Smith; Katrina Sullivan; Shane G Hayes; Mathieu Assal; Gayle E Reiber
Journal:  J Rehabil Res Dev       Date:  2005 Sep-Oct

6.  [Lower extremity amputations in diabetic patients: a case-control study].

Authors:  Mônica Antar Gamba; Sabina Léa Davidson Gotlieb; Denise Pimentel Bergamaschi; Lucila A C Vianna
Journal:  Rev Saude Publica       Date:  2004-07-08       Impact factor: 2.106

7.  Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.

Authors:  Michael R Sargen; Ole Hoffstad; David J Margolis
Journal:  J Diabetes Complications       Date:  2012-10-11       Impact factor: 2.852

Review 8.  The Dellon approach to neurolysis in the neuropathy patient with chronic nerve compression.

Authors:  A L Dellon
Journal:  Handchir Mikrochir Plast Chir       Date:  2008-12-02       Impact factor: 1.018

9.  Diabetes in the elderly: the Oxford Community Diabetes Study.

Authors:  H A Neil; A V Thompson; M Thorogood; G H Fowler; J I Mann
Journal:  Diabet Med       Date:  1989 Sep-Oct       Impact factor: 4.359

10.  Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009.

Authors:  Boon How Chew; Ismail Mastura; Sazlina Shariff-Ghazali; Ping Yein Lee; Ai Theng Cheong; Zaiton Ahmad; Sri Wahyu Taher; Jamaiyah Haniff; Feisul Idzwan Mustapha; Mohd Adam Bujang
Journal:  Cardiovasc Diabetol       Date:  2012-05-18       Impact factor: 9.951

View more
  76 in total

Review 1.  Immune aging in diabetes and its implications in wound healing.

Authors:  J Moura; P Madureira; E C Leal; A C Fonseca; E Carvalho
Journal:  Clin Immunol       Date:  2019-02-05       Impact factor: 3.969

2.  Wound assessment, imaging and monitoring systems in diabetic foot ulcers: A systematic review.

Authors:  Kai Siang Chan; Zhiwen Joseph Lo
Journal:  Int Wound J       Date:  2020-08-23       Impact factor: 3.315

Review 3.  Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.

Authors:  Kimberly N Walter; Julie A Wagner; Eda Cengiz; William V Tamborlane; Nancy M Petry
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

4.  Metataxonomic approach to decipher the polymicrobial burden in diabetic foot ulcer and its biofilm mode of infection.

Authors:  Karthika Suryaletha; Joby John; Megha Periyappilly Radhakrishnan; Sanil George; Sabu Thomas
Journal:  Int Wound J       Date:  2018-01-22       Impact factor: 3.315

5.  A Small Chimeric Fibronectin Fragment Accelerates Dermal Wound Repair in Diabetic Mice.

Authors:  Denise C Hocking; James R Brennan; Carol H Raeman
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-11-01       Impact factor: 4.730

6.  Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds.

Authors:  Jiasheng Xu; Dinghong Min; Guanghua Guo; Xincheng Liao; Zhonghua Fu
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

7.  Foot care knowledge, attitudes and practices among patients with diabetic foot and amputation in St. Kitts and Nevis.

Authors:  Gracelyn Hanley; Piao-Yi Chiou; Chieh-Yu Liu; Hui-Mei Chen; Stefani Pfeiffer
Journal:  Int Wound J       Date:  2020-08-03       Impact factor: 3.315

Review 8.  Diabetes epidemic sweeping the Arab world.

Authors:  Bisher Abuyassin; Ismail Laher
Journal:  World J Diabetes       Date:  2016-04-25

9.  [Development of a Diabetic Foot Ulceration Prediction Model and Nomogram].

Authors:  Eun Joo Lee; Ihn Sook Jeong; Seung Hun Woo; Hyuk Jae Jung; Eun Jin Han; Chang Wan Kang; Sookyung Hyun
Journal:  J Korean Acad Nurs       Date:  2021-06       Impact factor: 0.984

10.  Specific foot health-related quality-of-life impairment in patients with type II versus type I diabetes.

Authors:  Patricia Palomo-López; Marta Elena Losa-Iglesias; Ricardo Becerro-de-Bengoa-Vallejo; Daniel López-López; David Rodríguez-Sanz; Carlos Romero-Morales; César Calvo-Lobo
Journal:  Int Wound J       Date:  2018-08-30       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.